Interesting that the article makes reference to 70% and not 75%. Journo error or does this go back to the 5% Cominiere transferred to Dathomir as per IGF report.
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
